These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17613888)

  • 1. Initial rate analysis of zoniporide hydrolysis degradants using high-performance liquid chromatography coupled with mass spectrometric detection.
    Kadar EP; Darrington RT
    Pharm Dev Technol; 2007; 12(3):247-57. PubMed ID: 17613888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoniporide: a potent and selective inhibitor of the human sodium-hydrogen exchanger isoform 1 (NHE-1).
    Tracey WR; Allen MC; Frazier DE; Fossa AA; Johnson CG; Marala RB; Knight DR; Guzman-Perez A
    Cardiovasc Drug Rev; 2003; 21(1):17-32. PubMed ID: 12595915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoniporide: a potent and highly selective inhibitor of human Na(+)/H(+) exchanger-1.
    Marala RB; Brown JA; Kong JX; Tracey WR; Knight DR; Wester RT; Sun D; Kennedy SP; Hamanaka ES; Ruggeri RB; Hill RJ
    Eur J Pharmacol; 2002 Sep; 451(1):37-41. PubMed ID: 12223226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
    Darrington RT; Jiao J
    J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical stability of amorphous materials: specific and general media effects in the role of water in the degradation of freeze-dried zoniporide.
    Luthra SA; Shalaev EY; Medek A; Hong J; Pikal MJ
    J Pharm Sci; 2012 Sep; 101(9):3110-23. PubMed ID: 22461087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of Reconstituted Telavancin Drug Product in Frozen Intravenous Bags.
    Gu Z; Wong A; Raquinio E; Nguyen A
    Hosp Pharm; 2015 Jul; 50(7):609-14. PubMed ID: 26448673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility.
    Guzman-Perez A; Wester RT; Allen MC; Brown JA; Buchholz AR; Cook ER; Day WW; Hamanaka ES; Kennedy SP; Knight DR; Kowalczyk PJ; Marala RB; Mularski CJ; Novomisle WA; Ruggeri RB; Tracey WR; Hill RJ
    Bioorg Med Chem Lett; 2001 Mar; 11(6):803-7. PubMed ID: 11277524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective efficacy of zoniporide, a potent and selective inhibitor of Na+/H+ exchanger isoform 1, in an experimental model of cardiopulmonary bypass.
    Clements-Jewery H; Sutherland FJ; Allen MC; Tracey WR; Avkiran M
    Br J Pharmacol; 2004 May; 142(1):57-66. PubMed ID: 15037516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry heat forced degradation of buserelin peptide: kinetics and degradant profiling.
    D'Hondt M; Fedorova M; Peng CY; Gevaert B; Taevernier L; Hoffmann R; De Spiegeleer B
    Int J Pharm; 2014 Jun; 467(1-2):48-9. PubMed ID: 24657556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed-phase liquid chromatography with electrospray mass detection and 1H and 13C NMR characterization of new process-related impurities, including forced degradants of efavirenz: related substances correlated to the synthetic pathway.
    Gadapayale K; Kakde R; Sarma VU
    J Sep Sci; 2015 Jan; 38(2):218-30. PubMed ID: 25385054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling degradants of paclitaxel using liquid chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry substructural techniques.
    Volk KJ; Hill SE; Kerns EH; Lee MS
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(1):99-115. PubMed ID: 9300914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of low-level degradants from low dose tablets.
    Blanchard A; Lee C; Nickerson B; Lohr LL; Jensen AJ; Alsante KM; Sharp TR; Santafianos DP; Morris R; Snyder KD
    J Pharm Biomed Anal; 2004 Oct; 36(2):265-75. PubMed ID: 15496319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural characterization of low level degradants in aztreonam injection and an innovative approach to aid HPLC method validation.
    Ye Q; Ding W; Rinaldi F; Huang Y; Miller SA; Bolgar M
    J Pharm Biomed Anal; 2016 May; 124():358-364. PubMed ID: 26991056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of structural variation on aldehyde oxidase-catalyzed oxidation of zoniporide.
    Dalvie D; Sun H; Xiang C; Hu Q; Jiang Y; Kang P
    Drug Metab Dispos; 2012 Aug; 40(8):1575-87. PubMed ID: 22587988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir.
    Huang Y; Su BN; Marshall J; Miller SA
    J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism-based kinetic analysis of succinimide-mediated deamidation, racemization, and covalent adduct formation in a model peptide in amorphous lyophiles.
    Dehart MP; Anderson BD
    J Pharm Sci; 2012 Sep; 101(9):3096-109. PubMed ID: 22271437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acyclovir chemical kinetics with the discovery and identification of newly reported degradants and degradation pathways involving formaldehyde as a degradant and reactant intermediate.
    Bejgum BC; Johnson PR; Stagner WC
    Int J Pharm; 2018 Jan; 535(1-2):172-179. PubMed ID: 29061324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interspecies variation in the metabolism of zoniporide by aldehyde oxidase.
    Dalvie D; Xiang C; Kang P; Zhou S
    Xenobiotica; 2013 May; 43(5):399-408. PubMed ID: 23046389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structure elucidation of major alkaline degradant of ezetimibe.
    Gajjar AK; Shah VD
    J Pharm Biomed Anal; 2011 Apr; 55(1):225-9. PubMed ID: 21288678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse postresuscitation myocardial effects elicited by buffer-induced alkalemia ameliorated by NHE-1 inhibition in a rat model of ventricular fibrillation.
    Lamoureux L; Radhakrishnan J; Mason TG; Kraut JA; Gazmuri RJ
    J Appl Physiol (1985); 2016 Nov; 121(5):1160-1168. PubMed ID: 27633736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.